Trial intelligence / Profile preview

Sequential Teriparatide and Raloxifene for Osteoporosis

NCT01166958Phase 4Completed

Sponsor
University of Wisconsin–Madison
Start
Sep 2010
Primary completion
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raloxifene in osteoporosis, sponsored by University of Wisconsin–Madison. Started Sep 2010; status: completed.

02

Drugs

raloxifene
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT01166958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01166958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call